|
|
There were sufficient data to recommend the evaluation and clinical monitoring of persons with mild cognitive impairment due to their increased risk for developing dementia. Screening instruments, e.g., Mini-Mental State Examination, were f ound to be useful to the clinician for assessing the degree of cognitive impairment (Guideline), as were neuropsychologic batteries, brief focused cognitive instruments, and certain structured informant interviews. Increasing attention is being paid to p ersons with mild cognitive impairment for whom treatment options are being evaluated that may alter the rate of progression to dementia. |
|